Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Pandox acquires seven hotel properties in Germany for MEUR 290

Pandox AB (publ) has entered into an agreement to acquire seven hotel properties with a total of 1,532 rooms in Germany from HR Group. The total transaction value amounts to approximately MEUR 290, excluding minority. The acquisition is expected to be financed by liquid funds and new bank loans. The hotels will continue to be managed by HR Group under fixed leases with indexation, which will be converted into revenue-based leases by 2024 at the latest. The hotels are expected to contribute approximately MEUR 16.5 in rental income and MEUR 16.4 in net operating income, on an annualised basis.

Aker ASA: Disclosure of shareholdings and primary insider notice

Reference is made to the stock exchange release published by Ocean Yield ASA (“Ocean Yield”, “the Company”) on 21 November 2019 regarding a private placement of up to 15,935,143 new shares in Ocean Yield (“the Private Placement”). Aker Capital AS (“Aker”), a wholly owned subsidiary of Aker ASA and the largest shareholder in Ocean Yield with an ownership of 61.65 per cent, pre-subscribed and was allocated 9,824,257 new shares in the Private Placement. The allocation is equivalent to Aker’s pro-rata ownership. Aker has also entered into a share lending agreement with Arctic Securities

Primary insider disclosure

Reference is made to the stock exchange release published by Ocean Yield ASA (“Ocean Yield”, “the Company”) on 21 November 2019 regarding a private placement of up to 15,935,143 new shares in the Company (“the Private Placement”).   Erøy AS, a company controlled by Øyvind Eriksen, President and CEO of Aker ASA, the majority shareholder of Ocean Yield, was allocated 75,000 shares in the Private Placement, at a purchase price of NOK 45. Following completion of the Private Placement, Erøy AS holds 325,000 shares in the Company, constituting 0.19 per cent of the Company’s shares and votes.

OCEAN YIELD: PRIVATE PLACEMENT SUCCESSFULLY COMPLETED

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange release by Ocean Yield ASA (“Ocean Yield” or the “Company”) on 21 November 2019 regarding a contemplated fully underwritten private placement (the “Private Placement”) of 15,935,143 new ordinary shares in the Company.

ASTG releases video interview with CEO, Carsten Drachmann

ASTG has released a video where CEO, Carsten Drachmann, explains the ASTG business and future direction."I saw the potential of ASTG's product portfolio and combined with growing markets, there is definitely a potential for the company to grow. I like working in high-tech environments with smart people, and I am very committed to do my utmost for the benefit of the company, our employees and our shareholders". November 22, 2019

IRRAS Announces FDA Clearance of New 510(K) Filing to Expand the Time of Use of IRRAflow®

Stockholm, November 21, 2019 – IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that the US FDA has cleared a new 510(K) for IRRAflow. The application provided the FDA with supporting data demonstrating that extending the time of use of the product is safe and has the potential to be beneficial for patients. IRRAflow is the world’s first irrigating ventricular drain. Its unique mechanism of action addresses the complications associated with the current methods of managing intracranial fluid by using a dual

Vonovia currently controls 72.3% of the votes in Hembla

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD VIOLATE THE LAWS OF SUCH JURISDICTION.  DETAILED INFORMATION ABOUT THE OFFER, INCLUDING THE OFFER DOCUMENT, IS AVAILABLE AT https://en.vonovia-h.de.PRESS RELEASE · Following completion of the acquisition of Blackstone’s shares in Hembla and purchase of shares in the market, Vonovia currently owns approximately 72.3% of the voting rights (approximately 65.0% of the share capital) in Hembla · Statement from Hembla’s independent bid committee regarding the

Fotografiska Stockholm opens Alex Prager Welcome Home

Alex Prager  Welcome Home 22nd November 2019-8th March 2020 Fotografiska Stockholm Born and raised in Los Angeles, Alex Prager’s inherent connection to Hollywood and her love of cinema, is as obvious as it is fascinating. Describing the city’s Wild West quality of no rules as one of her greatest inspirations, Prager started with guerilla style photography and film and then moved into more elaborately staged tableaux’s inspired by her personal life and the state of society. In Welcome Home at Fotografiska Stockholm, Prager seeks out the darker side of human nature, or reality,

Calquence approved in CLL in the US

21 November 2019 18:10 GMT   Calquence approved in the USfor adult patients with chronic lymphocytic leukaemia  Two Phase III Calquence trials demonstrated superior progression-free survival across multiple settings while maintaining favourable tolerability  Calquence combined with obinutuzumab and as monotherapy reducedthe risk of disease progression or death by 90% and 80%,respectively in ELEVATE-TN   AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic

A Distant Land close to us all – Pentti Sammallahti at Fotografiska Stockholm

Pentti Sammallahti Distant Land 22 November 2019-8 March Fotografiska Stockholm “In the Eye of the Beholder” is a beautiful saying full of mystery. What is actually in the eye of the beholder, how much of yourself is in every observation you make? And are you aware of how much your interpretation is part of a creation? There is a need for mystery in the materialistic Western world. And the work of Pentti Sammallahti meets those needs in the most gentle, humoristic and thoughtful way. A poetic observer with a unique and inclusive eye to the world around him, recognized as a master

Nordic Nanovector ASA - Financial calendar

Oslo, Norway, 21 November 2019 FINANCIAL YEAR 2019 27.02.2020 - Quarterly Report - Q4   FINANCIAL YEAR 2020 17.04.2020 - Annual General Meeting 26.05.2020 - Quarterly Report - Q1 27.08.2020 - Half-yearly Report - Q2 19.11.2020 - Quarterly Report - Q3   The dates are subject to change. The time and location of the presentations will be announced in due time.   This information is published pursuant to the requirements set out in the Continuing obligations.   For further information, please contact:  IR enquiries Malene Brondberg, VP Investor

BATTLETECH: Heavy Metal Expansion Now Available on Steam for PC, Mac, and Linux

Award-Winning Turn-Based Tactical ‘Mech Combat Game from Paradox Interactive Introduces New ‘Mechs, Mini-Campaign and Weapon SystemsSTOCKHOLM - November 21, 2019 - Paradox Interactive and Harebrained Schemes today released Heavy Metal, the latest expansion to BATTLETECH, the turn-based tactical ‘Mech combat game for PC, Mac and Linux. Available for a suggested retail price of $19.99 / £15.49 / €19.99, and included as the final expansion in the BATTLETECH - Season Pass, Heavy Metal features eight new ‘Mechs each with unique equipment, a Flashpoint mini-campaign, and eight weapon systems.

Brighter invests in a digital healthcare provider and initiates partnership for digital health services

Brighter AB (publ) ("Brighter") has today entered into an agreement by which Brighter invests SEK 9 million in the healthcare provider Accumbo AB. The investment corresponds to approximately 13 percent of the shares and votes in Accumbo. The investment will be used for expansion and development of new services for both digital and physical healthcare. The partnership starts with Brighters diabetes service Actiste® and Accumbo's care service for high blood pressure. Since the launch of Blodtrycksdoktorn (“the Blood Pressure Doctor”) earlier this year, Accumbo has treated more than two

British innovation beneath some of the world’s biggest theme park rides

WHEN you’re on some of the best-known theme park rides in the world, you’ll be glad to know you’ve got the very best technology beneath your feet. British-made Marl LED panel indicator lamps have been the go-to equipment of choice for some of the most popular theme parks in North America for 20 years. Now the UK company is looking to other markets which would benefit from the high-spec, high quality, outstandingly reliable LED lamps. Marl’s 690 series lamps have been particularly popular in the theme park sector because of their ability to withstand high vibration. The lamps are

Bulletin from Annual General Meeting of Diamyd Medical AB

The Annual General Meeting of Diamyd Medical AB (publ) was held on November 21, 2019. The Company's income statement and balance sheet were adopted, and the Board members and the Chief Executive Officer were discharged from liability for the fiscal year 2018/2019. The Annual General Meeting approved the Board's proposal that no dividend be paid for the fiscal year 2018/2019. Erik Nerpin was re-elected as Chairman of the Board and Anders Essen-Möller, Maria-Teresa Essen-Möller, Torbjörn Bäckström and Mark A. Atkinson were re-elected to the Board. The Annual General Meeting approved

Press release from Annual General Meeting in Internationella Engelska Skolan i Sverige Holdings II AB (publ) on 21 November 2019

At the Annual General Meeting (AGM) in Internationella Engelska Skolan i Sverige Holdings II AB (publ) in Stockholm today the shareholders resolved upon the following: Approval of income statement and balance sheet for the financial year 2018/2019 and discharge from liability The AGM approved the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2018/2019, and the members of the board and the managing directors were discharged from liability for the financial year 2018/2019. Allocation of profit

Statement by the independent bid committee of Hembla in view of Vonovia’s cash offer

Hembla’s independent bid committee unanimously recommends the shareholders not to accept Vonovia’s cash offer. Background                                                                                                                         This statement is made by Hembla AB (publ)’s (“Hembla” or the “Company”) independent bid committee pursuant to section II.19 of the Nasdaq Stockholm takeover rules (the “Takeover Rules”). Vonovia SE[1], through its indirectly wholly-owned subsidiary HomeStar InvestCo AB[2] (“Vonovia”), has on 7 November 2019 announced a cash offer to the

Holiday Specials from California Inns

Holiday Specials from California Inns SACRAMENTO, CA [November 21, 2019]--Nestle into the warmth of the holidays with a stay at a California boutique inn or bed and breakfast. California inns welcome travelers with crackling fires, festive decor, and an array of holiday travel specials and packages. Guests who book any two-night stay at Olallieberry Inn  during Cambria Christmas Market will receive complementary tickets for two to the event. The market offers the opportunity to shop with artisan vendors, walk through over two million lights,

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.11.2019

Fiskars Corporation  NOTIFICATION 21.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.11.2019 Date 21.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.7702 EUR  Highest price/share 11.8200 EUR Lowest price/share 11.7400 EUR Total price  11,770.20 EUR  The shares held by Fiskars Corporation on 21.11.2019: FSKRS 385,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

OCEAN YIELD: FULLY UNDERWRITTEN PRIVATE PLACEMENT OF NEW SHARES

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Ocean Yield ASA (the “Company” or "Ocean Yield") has retained Arctic Securities AS, DNB Markets, part of DNB Bank ASA and Fearnley Securities AS as joint bookrunners (the “Joint Bookrunners”) and ING Bank N.V., SpareBank 1 Markets AS and Swedbank

ContextVision announces first digital pathology patent granted for its unique and objective data-generation method

STOCKHOLM – November 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announce today that its proprietary Master Annotation method has received patent protection in the U.S. The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”. ContextVision developed this method to automatically and more objectively outline specific structures in

Acquisition of four LR2 product tankers with long-term charter

Ocean Yield ASA ("Ocean Yield" or the "Company") is pleased to announce that the Company has agreed to acquire four modern LR2 product tankers with long-term charter to companies owned and guaranteed by Navig8 Topco Holdings Inc. (“Navig8 Group”) from a major Chinese leasing company. The net purchase price is around USD 132 million in total, or an average price of USD 33 million per vessel, depending on the closing date for each vessel, which is expected to be during the fourth quarter of 2019. The scrubber fitted vessels are built in 2018 and 2019 with about 9 year’s remaining bareboat

#19-1140 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact:Listing on +46 8 566 390 20 or at listings@ngm.se.  Nordic Growth Market NGM AB  About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

There are no items matching the current filter
There are no more items matching the current filter
Back to top